Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RALBP1 pseudogene 2 (RALBP1P2) is a non-coding pseudogene homologous to the RalA-binding protein 1 gene (RALBP1). Pseudogenes are DNA segments resembling functional genes but lack coding or regulatory capacity to produce proteins. As a pseudogene, RALBP1P2 does not have characterized molecular functions, disease roles, or interactions typical of therapeutic targets. Its sequence similarity to RALBP1 might allow it to participate in regulatory RNA interactions, such as competing for RNA binding proteins or modulating the stability of parental gene transcripts, but any biological effects are hypothetical and not established as therapeutic mechanisms. In contrast, RALBP1 is a multifunctional protein involved in receptor-mediated endocytosis, cell migration, and drug resistance, and is considered a potential therapeutic target in some cancers. If you are seeking structured data for an actionable therapeutic target, RALBP1 pseudogene 2 (RALBP1P2) is not suitable; the canonical entity is RalA-binding protein 1 (RALBP1).
None for RALBP1P2. RALBP1 acts as a transporter and efflux pump for certain drugs, but the pseudogene has no protein product or known mechanism of drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RALBP1 pseudogene 2 (RALBP1P2).